Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nereus Pharmaceuticals logo — Pioneering marine microbiology to develop advanced treatment...

Nereus Pharmaceuticals

Pioneering marine microbiology to develop advanced treatments for cancer, infections, and inflammation since 1998.

Founded 1998 Series E Total: $139.80M Biotechnology, Health Care

General Information

Company Name Nereus Pharmaceuticals
Founded Year 1998
Founders / Decision Makers
Team member Team member
Industries Biotechnology, Health Care
Funding Stage Series E
Social

Get notified when Nereus Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nereus Pharmaceuticals

Nereus Pharmaceuticals, Inc. is a biotechnology company that has been pioneering marine microbiology to develop advanced treatments for cancer, infections, and inflammation since 1998. The company focuses on discovering and developing therapeutics for oncology, infectious diseases, and inflammation, leveraging its marine microbiology technologies to identify and formulate drug candidates. In the field of oncology, Nereus Pharmaceuticals has developed notable drug candidates such as NPI-2358, a tumor vascular disrupting agent targeting solid tumors, and NPI-0052, a proteasome inhibitor aimed at treating solid tumors, lymphomas, and multiple myeloma. The company is headquartered in San Diego, California. In June 2010, Nereus Pharmaceuticals secured a significant $20.00M Series E investment from prominent investors including Advent International, HBM Healthcare Investments, Alta Partners, Forward Ventures, Astellas Venture Management, Roche Venture Fund, and Pacific Venture Group. This investment reflects the confidence of reputable venture capital firms in the potential of Nereus Pharmaceuticals' innovative approach to drug development within the biotechnology and healthcare industries.

Taxonomy: Marine microbiology, Therapeutics, Oncology, Infectious diseases, Inflammation, Drug discovery, NPI-2358, Tumor vascular disrupting agent, NPI-0052, Proteasome inhibitor, Solid tumors, Lymphomas, Multiple myeloma, San Diego, Biopharmaceutical

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series E •••••• 7
Investor Investor Investor Investor Investor Investor Investor
25 Jun 2010
Series D •••••• 3
Investor Investor Investor
09 Aug 2007
Series D •••••• - 19 Oct 2005
Series B •••••• - 30 Jul 2001
Series A •••••• - 17 Apr 2000

Nereus Pharmaceuticals Alternatives & Competitors

Nereus Pharmaceuticals vs
BioArdis
BioArdis United States

Motivated By Science

2 employees
Biotechnology, Health Care
Nereus Pharmaceuticals vs
Gibson Oncology, LLC
Gibson Oncology, LLC

- Tough on cancer. Not on Patients.

4 employees
Biotechnology, Health Care
Nereus Pharmaceuticals vs
Avistone Biotechnology Co., Inc
Avistone Biotechnology Co., Inc

Avistone is an Innovative Global Oncology Company Focused on Targeted Therapeutics for Lung Cancer

Series B
5 employees
Biotechnology

FAQ About Nereus Pharmaceuticals

Pioneering marine microbiology to develop advanced treatments for cancer, infections, and inflammation since 1998.
Nereus Pharmaceuticals was founded in 1998.
Nereus Pharmaceuticals operates in the following industries: Biotechnology, Health Care.
Nereus Pharmaceuticals has completed 5 funding rounds, raising a total of $139.80M. The latest funding stage is Series E.
Top alternatives and competitors to Nereus Pharmaceuticals include BioArdis, Gibson Oncology, LLC , Avistone Biotechnology Co., Inc, NBE-Therapeutics AG, CytRx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nereus Pharmaceuticals and BioArdis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nereus Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy